register

News - MedTech & Diagnostics

Australia’s private hospitals join the COVID-19 fight in new partnership

Health Industry Hub | April 1, 2020 |

A new partnership with the Commonwealth Government will guarantee the viability of Australia’s private hospital sector, ensuring its full capacity is available for the COVID-19 pandemic response.

Health Minister Greg Hunt announced the agreement on 31 March, saying the Commonwealth would underwrite private hospitals to keep them open, clinicians employed and high quality private hospital care available to Australians.

Australian Private Hospital Association (APHA) CEO Michael Roff welcomed the move, saying it gave the sector some certainty in challenging times.

“This is about private hospitals stepping up to the plate and doing whatever is required to help the country get through this pandemic.

Customer engagement during COVID-19. Fill the gap of reduced fieldforce activities. Health Industry Hub combines expertise in digital marketing and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.

Mr Roff said hospital capacity would be offered under a cost recovery basis so the 657 hospitals, 35,000 beds, 100,000 staff including 57,000 nurses are available and integrated into the pandemic response to create one health system devoted to that response – that is the number one goal of this deal.

This may come as a relief to the healthcare industry following the recent MJA publication on the surge capacity of Australian intensive care units associated with COVID-19 admissions.

Mr Roff said the deal also means there will be a private hospital system on the other side of the crisis.

“While the health system responds to the pandemic, a lot of what it normally does must be deferred. When the pandemic is over, we are going to need all of the capacity of the private hospital system to deal with the backlog of essential surgery. This deal means the private hospital system will be there to address that backlog.

“This is definitely not business as usual and everybody working in the health system needs to understand that what they were doing three or four weeks ago is not what they will be doing in three or four weeks’ time.

“The states and territories now need to urgently finalise deals with private hospitals. We think the Victorian proposal provides a good model that could be picked up by other states to ensure there is no delay in reaching agreements,” he said.

Register FREE and join 20,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

You may also like Medtronic’s landmark trial shows superiority for renal denervation in patients with high blood pressure


News - Pharmaceuticals

Inside the tensions shaping PBAC decision

Inside the tensions shaping PBAC decision

Health Industry Hub | September 17, 2026 |

The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]

More


News - MedTech & Diagnostics

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

Health Industry Hub | September 17, 2026 |

GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]

More


News - MedTech & Diagnostics

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

Health Industry Hub | September 17, 2026 |

The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]

More


News - Pharmaceuticals

New breast cancer drug fills gap left by Zoladex market withdrawal

New breast cancer drug fills gap left by Zoladex market withdrawal

Health Industry Hub | September 17, 2026 |

From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]

More


This content is copyright protected. Please subscribe to gain access.